Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Male gynecomastia.

Literature DB >> 19648382

Male gynecomastia.

Bridgett A Haynes¹, Farouk Mookadam.

Abstract

Entities: Disease

Mesh：

Substances：
Spironolactone

Year: 2009 PMID： 19648382 PMCID： PMC2719518 DOI： 10.1016/S0025-6196(11)60515-6

Source DB: PubMed Journal: Mayo Clin Proc ISSN： 0025-6196 Impact factor: 7.616

× No keyword cloud information.

6 in total

1. Pathophysiology of spironolactone-induced gynecomastia.

Authors: L I Rose; R H Underwood; S R Newmark; E S Kisch; G H Williams
Journal: Ann Intern Med Date: 1977-10 Impact factor: 25.391

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors: Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal: N Engl J Med Date: 2003-03-31 Impact factor: 91.245

3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors: B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal: N Engl J Med Date: 1999-09-02 Impact factor: 91.245

4. Effect of spironolactone on blood pressure in subjects with resistant hypertension.

Authors: Neil Chapman; Joanna Dobson; Sarah Wilson; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Journal: Hypertension Date: 2007-02-19 Impact factor: 10.190

Review 5. Gynecomastia and hypertension.

Authors: L Michael Prisant; Edward Chin
Journal: J Clin Hypertens (Greenwich) Date: 2005-04 Impact factor: 3.738

Male gynecomastia.

1. Pathophysiology of spironolactone-induced gynecomastia.

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

4. Effect of spironolactone on blood pressure in subjects with resistant hypertension.

Review 5. Gynecomastia and hypertension.

Review 6. Gynecomastia and antihypertensive therapy.

1. Gynecomastia.

2. What is this image? 2021 image 4 result : Staying abreast of amyloid?

3. The male mammary gland: a target for the xenoestrogen bisphenol A.

4. Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event.

Review 5. Gynecomastia and drugs: a critical evaluation of the literature.

6. Spironolactone-Induced Unilateral Gynecomastia.